Loading stock…

JBT Marel Corporation (JBTM) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

JBTMJBT Marel

Revenue FY25$3.8B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+34%10

Revenue, next 1Y+6%5

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR-10%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+17%8

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 34%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Earnings are set to grow faster than sales (EPS about 11%/yr vs revenue 4%/yr), so margins should widen.

WATCH

Revenue grew 34%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to shrink 10%/yr, behind 90% of companies worldwide.1/10

BOTTOM LINE

Margin Expander

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK4 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-25%1

YTD return-31%1

MID & LONG-TERM▾SCORE

% of 52-week high61%2

1-year return-28%2

3-year return+2%3

5-year return-27%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+1.9% over three years and -27% over five), behind 70% of the market.

It's down 28% over the past year, now 39% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-25%) and so far this year (-31%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on JBT Marel Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

JBTMJBT Marel

Revenue FY25$3.8B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+34%10

Revenue, next 1Y+6%5

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR-10%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+17%8

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 34%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Earnings are set to grow faster than sales (EPS about 11%/yr vs revenue 4%/yr), so margins should widen.

WATCH

Revenue grew 34%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to shrink 10%/yr, behind 90% of companies worldwide.1/10

BOTTOM LINE

Margin Expander

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK4 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-25%1

YTD return-31%1

MID & LONG-TERM▾SCORE

% of 52-week high61%2

1-year return-28%2

3-year return+2%3

5-year return-27%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+1.9% over three years and -27% over five), behind 70% of the market.

It's down 28% over the past year, now 39% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-25%) and so far this year (-31%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on JBT Marel Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

JBT Marel Corporation

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on JBT Marel Corporation. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on JBT Marel Corporation. Get the full investment case.

Premium